capsaicin has been researched along with arvanil in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 25 (75.76) | 29.6817 |
| 2010's | 6 (18.18) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Appendino, G; De Petrocellis, L; Di Marzo, V; Minassi, A; Morello, AS | 1 |
| Anthes, JC; Correll, CC; Greenfeder, S; Phelps, PT; Umland, S | 1 |
| Bifulco, M; Bisogno, T; Chuang, H; De Petrocellis, L; Di Marzo, V; Julius, D; Melck, D | 1 |
| Di Marzo, V; Szallasi, A | 1 |
| Bisogno, T; Davis, JB; De Petrocellis, L; Di Marzo, V; Pertwee, RG | 1 |
| Bisogno, T; Breivogel, C; Di Marzo, V; Martin, BR; Melck, D; Patrick, G; Razdan, RK; Szallasi, A; Tao, Q | 1 |
| Brockie, HC; Craib, SJ; Di Marzo, V; Gibson, TM; Leslie, M; Pashmi, G; Pertwee, RG; Ross, RA | 1 |
| Bisogno, T; Brandi, I; Dasse, O; Davis, JB; De Petrocellis, L; Di Marzo, V; Jefferson, RG; Mahadevan, A; Martin, BR; Razdan, RK; Winckler, RL | 1 |
| Bifulco, M; Bisogno, T; De Petrocellis, L; Di Marzo, V; Melck, D; Orlando, P; Vogel, Z; Zagoory, O | 1 |
| Bisogno, T; Brandi, I; De Petrocellis, L; Di Marzo, V; Grier, MC; Griffin, G; Kulasegram, S; Mahadevan, A; Martin, BR; Razdan, RK; Williams, W | 1 |
| Baker, D; Bifulco, M; Bisogno, T; Bridges, D; Brooks, JW; Brown, P; Di Marzo, V; Hankey, DJ; Jaggar, SI; Ledent, C; Pryce, G; Rice, AS | 1 |
| Chiang, HT; Lo, YK; Wu, SN | 1 |
| Abumrad, NA; Deutsch, DG; Fatade, F; Glaser, ST; Kaczocha, M; Studholme, KM | 1 |
| Bär, PR; Di Marzo, V; Fezza, F; Maccarrone, M; Nicolay, K; van der Stelt, M; van Zadelhoff, G; Veldhuis, WB; Veldink, GA; Vliegenthart, JF; Wadman, MW | 1 |
| Appendino, G; de la Vega, L; Di Marzo, V; Macho, A; Munoz, E; Sancho, R | 1 |
| Aliev, AE; Baker, D; Hiley, R; Hoi, PM; Okuyama, M; Riddall, D; Selwood, DL; Visintin, C | 1 |
| Anthes, JC; Correll, CC; Phelps, PT | 1 |
| de Lago, E; Di Marzo, V; Fernández-Ruiz, J; Ramos, JA; Urbani, P | 1 |
| Andersson, TL; Evilevitch, V; Högestätt, ED; Jönsson, BA; Movahed, P; Wollmer, P; Zygmunt, PM | 1 |
| Bifulco, M; Bisogno, T; Di Marzo, V; Grimaldi, C; Laezza, C; Lechler, RI; Malfitano, AM; Matarese, G; Pisanti, S | 1 |
| Cabranes, A; de Lago, E; Di Marzo, V; Fernández-Ruiz, J; Fezza, F; García-Merino, A; Mestre, L; Ramos, JA; Sánchez, A; Valenti, M; Venderova, K | 1 |
| Appendino, G; Caballero, FJ; De Petrocellis, L; Di Marzo, V; Macho, A; Márquez, N; Minassi, A; Muñoz, E; Schiano-Moriello, A | 1 |
| Cichewicz, DL; Haller, VL; Welch, SP | 1 |
| Bifulco, M; De Petrocellis, L; Eletto, D; Gazzerro, P; Husain, S; Laezza, C; Malfitano, AM; Orlando, P; Schwalb, M; Terskiy, A; Toruner, GA; Vitale, E | 1 |
| Cristino, L; Davison, JS; Di Marzo, V; Guglielmotti, V; Oland, LD; Pittman, QJ; Sharkey, KA; Starowicz, K; Van Sickle, MD | 1 |
| Kopczyńska, B | 2 |
| Beattie, RE; Knopp, K; Liu, B; Sher, E; Ursu, D | 1 |
| Chirasani, SR; Cravatt, BF; Cristino, L; De Petrocellis, L; Di Marzo, V; Dittmar, G; Glass, R; Gurok, U; Imperatore, R; Kettenmann, H; Kumar, J; Lewin, GR; Ligresti, A; Matyash, V; Momma, S; Nuber, UA; Petrosino, S; Purfürst, B; Smith, ES; Stock, K; Synowitz, M; Wälzlein, JH; Wend, P | 1 |
| Barrière, DA; Blomgren, A; Chapuy, E; Daulhac, L; Eschalier, A; Etienne, M; Högestätt, ED; Libert, F; Mallet, C; Simonsen, C; Zygmunt, PM | 1 |
| Akers, AT; Brown, KC; Dasgupta, P; Friedman, JR; Hurley, JD; Nolan, NA | 1 |
| Bartusik-Aebisher, D; Florek-Łuszczki, M; Kołodziejczyk, P; Tutka, P; Wlaź, A; Łuszczki, JJ | 1 |
| Aldossary, SA; Alsalem, M; Altarifi, A; Azab, B; El-Salem, K; Haddad, M; Jaffal, SM; Kalbouneh, H; Mustafa, AG | 1 |
1 review(s) available for capsaicin and arvanil
| Article | Year |
|---|---|
New perspectives on enigmatic vanilloid receptors.
Topics: Animals; Arachidonic Acids; Brain Chemistry; Cannabinoid Receptor Modulators; Capsaicin; Diterpenes; Drug Design; Endocannabinoids; Forecasting; Ganglia, Spinal; Glycerides; Humans; Ligands; Nerve Tissue Proteins; Neurons, Afferent; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 2000 |
32 other study(ies) available for capsaicin and arvanil
| Article | Year |
|---|---|
N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor.
Topics: Amides; Animals; Binding Sites; Capsaicin; Cell Line; Fatty Acids; Ganglia, Spinal; Humans; In Vitro Techniques; Rats; Receptors, Drug; Terpenes; Vanillic Acid | 2002 |
Cloning and pharmacological characterization of mouse TRPV1.
Topics: Amino Acid Sequence; Animals; Calcium; Capsaicin; Cell Line; Cloning, Molecular; Cyclic AMP-Dependent Protein Kinases; Diterpenes; Enzyme Activation; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Intracellular Space; Ion Channels; Mice; Phorbol Esters; Phosphorylation; Rabbits; Rats; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; TRPV Cation Channels | 2004 |
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Binding Sites; Biological Transport; Capsaicin; Cell Division; Cell Line; Cell Membrane; Diffusion; Electric Conductivity; Endocannabinoids; Fatty Acids, Unsaturated; Humans; Ligands; Mice; Oocytes; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Xenopus laevis | 1999 |
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
Topics: Animals; Arachidonic Acids; Binding, Competitive; Biological Transport; Calcium; Capsaicin; Cell Line; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Ligands; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug; TRPV Cation Channels; Tumor Cells, Cultured | 2000 |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
Topics: Analgesics; Animals; Arachidonic Acids; Behavior, Animal; Brain; Cannabinoid Receptor Modulators; Capsaicin; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Male; Mice; Mice, Inbred ICR; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug | 2000 |
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Topics: Animals; Arachidonic Acids; Benzoxazines; Binding, Competitive; Biological Transport; Calcium; Calcium Channel Blockers; Cannabinoids; Capsaicin; CHO Cells; Cricetinae; Drug Interactions; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Male; Mice; Morpholines; Muscle Contraction; Naphthalenes; Phenylmethylsulfonyl Fluoride; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Structure-Activity Relationship; Transfection; TRPV Cation Channels; Vas Deferens | 2001 |
Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
Topics: Animals; Arachidonic Acids; Benzoxazines; Binding, Competitive; Calcium; Capsaicin; Cell Line; Cyclohexanols; Cytosol; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Ligands; Membranes; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Tritium; TRPV Cation Channels; Tumor Cells, Cultured | 2001 |
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arachidonic Acids; Blotting, Western; Breast Neoplasms; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Cell Division; Colforsin; COS Cells; Cyclic AMP; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Glycerides; Humans; Hydrolysis; Inhibitory Concentration 50; Palmitic Acids; Polyunsaturated Alkamides; Protein Binding; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured | 2001 |
A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Carrier Proteins; Cytosol; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Mice; Motor Activity; Pain Measurement; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug | 2002 |
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
Topics: Animals; Arachidonic Acids; Benzoxazines; Camphanes; Cannabinoid Receptor Modulators; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Genotype; Mice; Mice, Inbred Strains; Mice, Knockout; Morpholines; Multiple Sclerosis; Muscle Spasticity; Naphthalenes; Pain; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2002 |
Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells.
Topics: Action Potentials; Animals; Arachidonic Acids; Calcium Channels, L-Type; Capsaicin; Cell Line; Delayed Rectifier Potassium Channels; Drug Interactions; Endocannabinoids; Glycerol; Hybrid Cells; Mice; Neurons; omega-Conotoxin GVIA; Pertussis Toxin; Polyunsaturated Alkamides; Potassium Channels; Potassium Channels, Voltage-Gated; Rats | 2003 |
Evidence against the presence of an anandamide transporter.
Topics: Arachidonic Acids; Astrocytoma; Biological Transport; Cannabinoids; Capsaicin; Carrier Proteins; Endocannabinoids; Humans; Immunohistochemistry; Kinetics; Neuroblastoma; Polyunsaturated Alkamides; Tumor Cells, Cultured | 2003 |
Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
Topics: Animals; Animals, Newborn; Arachidonic Acids; Blood Cells; Brain; Brain Chemistry; Brain Mapping; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Endocannabinoids; Ethanolamines; Fatty Acids, Unsaturated; Lipoxygenase; Male; Masoprocol; Nerve Degeneration; Neuroprotective Agents; Ouabain; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Drug | 2003 |
The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Capsaicin; Carrier Proteins; Caspase 8; Caspase Inhibitors; Caspases; Cells, Cultured; Cysteine Proteinase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Fas Ligand Protein; Fas-Associated Death Domain Protein; Humans; In Situ Nick-End Labeling; Jurkat Cells; Membrane Glycoproteins; Models, Biological; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Receptors, Drug; Signal Transduction; T-Lymphocytes; Time Factors; Transcription, Genetic | 2003 |
Membrane receptor probes: solid-phase synthesis of biotin-Asp-PEG-arvanil derivatives.
Topics: Aspartic Acid; Biotin; Biotinylation; Capsaicin; Cross-Linking Reagents; Molecular Probes; Molecular Structure; Photoaffinity Labels; Receptors, Cannabinoid | 2005 |
Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
Topics: Amino Acid Sequence; Animals; Biological Transport; Calcium; Capsaicin; Cell Line; Cloning, Molecular; Diterpenes; DNA, Complementary; Dogs; Dopamine; Dose-Response Relationship, Drug; Fluorometry; Genetic Vectors; Genotype; Humans; Molecular Sequence Data; Mutation, Missense; Phorbol Esters; Phylogeny; Pyrazines; Pyridines; Receptors, Drug; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Transfection | 2005 |
Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.
Topics: Animals; Brain Chemistry; Capsaicin; Convulsants; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Huntington Disease; Hyperkinesis; Male; Motor Activity; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley | 2005 |
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.
Topics: Adult; Arachidonic Acids; Benzylamines; Capsaicin; Endocannabinoids; Female; Forearm; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Plethysmography; Polyunsaturated Alkamides; Regional Blood Flow; Skin; TRPV Cation Channels | 2005 |
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis.
Topics: Animals; Arachidonic Acids; Blotting, Western; Body Weight; Cannabinoid Receptor Modulators; Capsaicin; CD4-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Drug Interactions; Encephalomyelitis, Autoimmune, Experimental; Endocannabinoids; Enzyme Activation; Female; Flow Cytometry; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Mice; Myelin Proteolipid Protein; Peptide Fragments; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-akt; Statistics, Nonparametric; Time Factors | 2006 |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arachidonic Acids; Basal Ganglia; Brain; Cannabinoid Receptor Modulators; Capsaicin; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Endocannabinoids; Gene Expression; Glycerides; Male; Multiple Sclerosis; Phosphodiesterase Inhibitors; Polyunsaturated Alkamides; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rolipram; TRPV Cation Channels | 2005 |
Iodinated N-acylvanillamines: potential "multiple-target" anti-inflammatory agents acting via the inhibition of t-cell activation and antagonism at vanilloid TRPV1 channels.
Topics: Amines; Capsaicin; Cell Cycle; Cell Proliferation; Humans; In Situ Nick-End Labeling; Interleukin-2; Iodine; Jurkat Cells; Lymphocyte Activation; NF-kappa B; Plasmids; Promoter Regions, Genetic; T-Lymphocytes; TRPV Cation Channels | 2006 |
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Topics: Acetaminophen; Amides; Analgesics; Animals; Arachidonic Acids; Benzamides; Benzoquinones; Camphanes; Capsaicin; Carbamates; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Ethanolamines; Hyperalgesia; Male; Mesencephalon; Mice; Mice, Inbred ICR; Narcotic Antagonists; Pain; Palmitic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid; Rimonabant; Spinal Cord; TRPV Cation Channels | 2006 |
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells.
Topics: Arachidonic Acids; Capsaicin; CD28 Antigens; CD3 Complex; CD36 Antigens; Endocannabinoids; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Oligonucleotide Array Sequence Analysis; Polyunsaturated Alkamides; Up-Regulation | 2007 |
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Topics: Acrylamides; Animals; Antiemetics; Arachidonic Acids; Area Postrema; Autonomic Pathways; Brain Stem; Bridged Bicyclo Compounds, Heterocyclic; Cannabinoids; Capsaicin; Dopamine; Emetics; Endocannabinoids; Ferrets; Male; Mice; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Solitary Nucleus; TRPV Cation Channels; Vagus Nerve; Vomiting | 2007 |
Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats.
Topics: Anilides; Animals; Blood Pressure; Cannabinoid Receptor Modulators; Capsaicin; Cinnamates; Disease Models, Animal; Endocannabinoids; Hypertension; Injections, Intravenous; Male; Morpholines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Respiration; Respiration Disorders; Ruthenium Red; Tidal Volume; TRPV Cation Channels | 2008 |
Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
Topics: Action Potentials; Alkaloids; Animals; Benzodioxoles; Capsaicin; Diterpenes; Ganglia, Spinal; Kinetics; Lipid Metabolism; Male; Neurons, Afferent; Pain; Patch-Clamp Techniques; Piperidines; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sensory Receptor Cells; Solubility; TRPV Cation Channels; Urea | 2010 |
Midcervical vagotomy precludes respiratory response to novel anti-inflammatory and anti-tumour drug arvanil in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Blood Pressure; Capsaicin; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Rats; Rats, Wistar; Respiratory Mechanics; Respiratory Physiological Phenomena; Tidal Volume; Vagotomy; Vagus Nerve | 2010 |
Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.
Topics: Aging; Amides; Amidohydrolases; Animals; Antineoplastic Agents; Apoptosis; Arachidonic Acids; Brain; Brain Neoplasms; Capsaicin; Cell Movement; Culture Media, Conditioned; Dopamine; Endocannabinoids; Ethanolamines; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Neoplasm Proteins; Neural Stem Cells; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; TRPV Cation Channels; Tumor Cells, Cultured | 2012 |
Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain.
Topics: Amidohydrolases; Aminophenols; Analgesics; Animals; Arachidonic Acids; Benzylamines; Brain; Capsaicin; Inhibitory Concentration 50; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nociception; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; TRPV Cation Channels; Vasodilation | 2013 |
Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers.
Topics: Adenylate Kinase; Animals; Capsaicin; Cell Line, Tumor; Humans; Lung Neoplasms; Neoplasm Invasiveness; Receptor, Cannabinoid, CB1; Signal Transduction; Small Cell Lung Carcinoma; Time Factors; TRPV Cation Channels | 2017 |
Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice.
Topics: Animals; Arachidonic Acids; Benzamides; Brain; Brain Waves; Cannabinoid Receptor Agonists; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Heterocyclic Compounds, 1-Ring; Male; Mice; Receptor, Cannabinoid, CB1; Seizures; Signal Transduction; Urea | 2018 |
The desensitization of the transient receptor potential vanilloid 1 by nonpungent agonists and its resensitization by bradykinin.
Topics: Animals; Bradykinin; Capsaicin; Hyperalgesia; Male; Mice; Mice, Inbred BALB C; Nociception; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sensory System Agents; TRPV Cation Channels | 2020 |